Tompkins Financial’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-162
| Closed | -$19.7K | – | 584 |
|
|
2024
Q4 | $19.7K | Hold |
162
| – | – | ﹤0.01% | 394 |
|
|
2024
Q3 | $20.2K | Hold |
162
| – | – | ﹤0.01% | 419 |
|
|
2024
Q2 | $25.6K | Hold |
162
| – | – | ﹤0.01% | 406 |
|
|
2024
Q1 | $21K | Hold |
162
| – | – | ﹤0.01% | 426 |
|
|
2023
Q4 | $15.6K | Hold |
162
| – | – | ﹤0.01% | 451 |
|
|
2023
Q3 | $19.6K | Hold |
162
| – | – | ﹤0.01% | 406 |
|
|
2023
Q2 | $18.6K | Hold |
162
| – | – | ﹤0.01% | 414 |
|
|
2023
Q1 | $22.3K | Hold |
162
| – | – | ﹤0.01% | 409 |
|
|
2022
Q4 | $21K | Hold |
162
| – | – | ﹤0.01% | 411 |
|
|
2022
Q3 | $18K | Hold |
162
| – | – | ﹤0.01% | 422 |
|
|
2022
Q2 | $12K | Hold |
162
| – | – | ﹤0.01% | 458 |
|
|
2022
Q1 | $13K | Hold |
162
| – | – | ﹤0.01% | 474 |
|
|
2021
Q4 | $15K | Hold |
162
| – | – | ﹤0.01% | 277 |
|
|
2021
Q3 | $15K | Buy |
+162
| New | +$15K | ﹤0.01% | 305 |
|
|
2021
Q1 | $12K | Hold |
162
| – | – | ﹤0.01% | 352 |
|
|
2020
Q4 | $28K | Hold |
162
| – | – | 0.01% | 295 |
|
|
2020
Q3 | $23K | Hold |
162
| – | – | ﹤0.01% | 290 |
|
|
2020
Q2 | $26K | Hold |
162
| – | – | 0.01% | 277 |
|
|
2020
Q1 | $16K | Buy |
+162
| New | +$16K | ﹤0.01% | 293 |
|